by maheshbhuva | Jun 15, 2026 | Analytical Chemistry, Documents error (DIN), Out of specification, Pharmaceutical interview,, QMS, Quality control (QC)
RCA (ROOT CAUSE ANALYSIS) IN PHARMACEUTICAL INDUSTRIES AS PER REGULATORY REQUIREMENTS 1. PROBLEM IDENTIFICATION What Happens Clearly define the deviation, OOS, OOT, complaint, breakdown, audit observation, or incident. Includes Deviation description Date & time...
by maheshbhuva | Jun 5, 2026 | Analytical Chemistry, Hplc
If you run high-performance liquid chromatography (HPLC) assay, you know that consistency is everything. In a validated method, your retention time (RT) should remain rock-steady from injection to injection. But every chromatographer eventually faces that frustrating...
by maheshbhuva | Jun 1, 2026 | Analytical Chemistry, Pharmacopea
These updates are quite significant because they reshape compliance expectations across different regions and therapeutic areas. Let me break down where the impact is most pronounced:🌍 Key Pharmacopoeia Updates- Indian Pharmacopoeia 2026 – 121 new...
by maheshbhuva | May 26, 2026 | Analytical Chemistry, Audit Trail, Quality control (QC)
🚀 Building Compliant LIMS Software: Key Audit Trail FeaturesDesigning a pharmaceutical LIMS requires a relentless focus on data integrity, 21 CFR Part 11 compliance, and ALCOA+ principles. Here are the core audit trail features I’m prioritizing for our software...
by maheshbhuva | May 20, 2026 | Analytical Chemistry, Out of specification, Pharmaceutical interview,, Quality control (QC)
Can we average an OOS result with passing retest results to get a passing average? A: Absolutely not. Both FDA and MHRA guidelines strictly prohibit averaging an OOS result with passing retests to “hide” the failure or bring the batch into compliance....
